ライフサイエンスコーパス: scintillation

1 adioluminescence, Cerenkov luminescence, and scintillation.

2 Column effluents were quantified by liquid scintillation.

3 iquid scintillation counting (LSC) or liquid scintillation analysis (LSA) method, though widely used

4 eactor bioshield using combustion and liquid scintillation analysis has identified two forms of (3)H,

5 is solution were counted in a Packard liquid scintillation analyzer; the mean radioactivity in becque

6 bind and excite the streptavidin-conjugated scintillation beads.

7 tion, but while the subject was experiencing scintillations, BOLD signal followed the retinotopic pro

8 tical axis in front of a stationary clinical scintillation camera equipped with a pinhole collimator.

9 ction of a dual-head variable-angle-geometry scintillation camera equipped with thicker crystals (5/8

10 A-IgG were co-injected into six subjects and scintillation camera images were acquired at 6 and 18 hr

11 ritumomab tiuxetan and assessed using planar scintillation camera imaging at 5 time points and CT-org

12 ed patient data available from a combined CT-scintillation camera imaging system.

13 ssessed by the imaging of animals on a gamma-scintillation camera using quantitative region-of-intere

14 total 67Cu photopeak counts detected with a scintillation camera were attributable to 64Cu.

15 ement techniques involving imaging by planar scintillation camera, SPECT and PET for the calculation

16 anted kidneys were obtained with a dual-head scintillation camera.

17 d radiation dose (TSARD) was determined from scintillation-camera conjugate views, and the tumor volu

18 Scintillation-camera imaging showed that tumor xenograft

19 ively fast and can be used to produce liquid scintillation cocktails e.g., via benzene synthesis.

20 es with good sensitivity, without the use of scintillation cocktails.

21 instead of detection of activity by a liquid scintillation counter (LSC), the compounds can be quanti

22 e spent all at once, plus an ancient Packard scintillation counter that had a series of rapidly flash

23 shed, and the radioactivity is measured in a scintillation counter.

24 ange of protons on glycine, which requires a scintillation counter.

25 canning of the TLC plate or by counting in a scintillation counter.

26 eceptor-bound radioactivity is detected in a scintillation counter.

27 ss [32P]PPi and then measuring [32P]ATP in a scintillation counter.

28 the supernatant, which is then counted in a scintillation counter; a linear increase in the release

29 Events are selected by requiring hits on scintillation counters mounted in the forward region of

30 r elution, (99)Tc is detected using a liquid scintillation counting (LSC) detector.

31 specific elapsed time intervals using liquid scintillation counting (LSC) for nanomolar concentration

32 The liquid scintillation counting (LSC) or liquid scintillation ana

33 of SO4 can be analyzed using current liquid scintillation counting (LSC) techniques.

34 and offline radiometric detection by liquid scintillation counting (LSC).

35 has been directly compared to that of liquid scintillation counting (LSC).

36 and ocular tissues were quantified by liquid scintillation counting (LSC).

37 r, both as FeSO4, was measured by whole-body scintillation counting 13 d after oral administration.

38 ed with X-ray film and quantitated by liquid scintillation counting after extraction from the gels.

39 into the proteins, was quantitated by liquid scintillation counting after gel solubilization by H2O2.

40 Labelled peptides were detected by on-line scintillation counting after immunoprecipitation and HPL

41 bel into the fusion proteins was measured by scintillation counting after sodium dodecyl sulfate-poly

42 at five time points in tissue extracts using scintillation counting and 13C nuclear magnetic resonanc

43 olabeled chemical in conjunction with liquid scintillation counting and accelerator mass spectrometry

44 in food samples using ultra low-level liquid scintillation counting and alpha-particle spectrometry.

45 times after injection and subjected to gamma-scintillation counting and autoradiography (ARG).

46 , P<0.05 in spleen), corroborated by ex vivo scintillation counting and autoradiography.

47 1.3+/-0.03; P<0.05), corroborated by ex vivo scintillation counting and autoradiography.

48 (1, 3, 7, 14, and 35 days) were analyzed by scintillation counting and HPLC to characterize the phar

49 on by mixed, undefined cultures using liquid scintillation counting and liquid chromatography with ra

50 both control and ARF rats, as detected using scintillation counting and whole-body ARG (10.56 +/- 1.0

51 ed by quantitative autoradiography and gamma-scintillation counting at 24 h after CED, 47.4% of the i

52 n from vinegar used in preparation of liquid scintillation counting cocktails for measurements of low

53 Autoradiography and scintillation counting confirmed the in vivo findings.

54 Ex vivo gamma-scintillation counting corrected for sham-operated nonsp

55 radiolabeled receptor-antibody complexes and scintillation counting enabled quantitation of the subty

56 tric approach using industry-standard liquid scintillation counting equipment that can both identify

57 wet chemistry digestion technique and liquid scintillation counting for (14)C activity measurements.

58 zed with this overall approach and by liquid scintillation counting for comparison.

59 ed using (11)C-erlotinib imaging and ex vivo scintillation counting in knockout and WT mice.

60 Whole-gut lavage and whole-body scintillation counting methods were applied to determine

61 intigraphically and measured distribution by scintillation counting of dissected tissues.

62 Material balance was measured by liquid scintillation counting of the starting samples, by LC/ra

63 , and the supernatant was measured by liquid scintillation counting prior to injection on the HPLC to

64 The routine application of liquid scintillation counting to (41)Ca determination has been

65 as empirically determined by HPLC and liquid scintillation counting to be 24.4 Ci/mmol, approximately

66 tometrically, and cathepsin D (CD) by liquid scintillation counting using [14C] hemoglobin as substra

67 merit similar to those obtained with liquid scintillation counting were achieved by exploiting a sim

68 amples with 3H activities measured by liquid scintillation counting were utilized to develop and vali

69 uantified using both MALDI-TOF-MS and liquid scintillation counting with (3)H-TPP.

70 se vial were calibrated using 4pibeta liquid scintillation counting with 3H-standard efficiency traci

71 h replaces the traditional radiolabeling and scintillation counting with fluorescent staining and dig

72 opriate region of the gel followed by liquid scintillation counting yields an isotope ratio which ref

73 in-agarose beads) and quantitative analysis (scintillation counting) of only the biotinylated glycope

74 as isolated, purified and analyzed by liquid scintillation counting, (2)H- or (13)C NMR or selective

75 d couples solid phase extraction with liquid scintillation counting, and scintillating anion exchange

76 The radioactivity was measured by scintillation counting, and the absolute disintegrations

77 values, measured experimentally using liquid scintillation counting, fit very well the expected value

78 aphy-mass spectrometry, (13)C- and (1)H-NMR, scintillation counting, HPLC, gas chromatography-flame i

79 nstituted enzyme mixture, followed by liquid scintillation counting, indicated that [14C]-8-MOP bindi

80 isolated and analyzed by NMR spectroscopy or scintillation counting, respectively.

81 eins on a glass fiber filter for analysis by scintillation counting, was designed to be fast and accu

82 try and validated by whole-body potassium-40 scintillation counting.

83 sing radiolabeled substrate, extraction, and scintillation counting.

84 rophoretic separation and autoradiography or scintillation counting.

85 H-thymidine into nuclear DNA as monitored by scintillation counting.

86 ed by quantitative autoradiography and gamma-scintillation counting.

87 and radiolabel incorporation was assayed by scintillation counting.

88 remained at specified times was measured by scintillation counting.

89 ransported protein was quantitated by liquid scintillation counting.

90 substrate and the radioactivity measured by scintillation counting.

91 portions of lenses were determined by liquid scintillation counting.

92 aper and the radioactivity was determined by scintillation counting.

93 ts were quantified by metabolic labeling and scintillation counting.

94 radiometric measurement of trapped 14CO2 by scintillation counting.

95 labeled products and their identification by scintillation counting.

96 cid precipitation of the protein followed by scintillation counting.

97 ed by quantitative autoradiography, TLC, and scintillation counting.

98 n each sample is less than that required for scintillation counting.

99 unoprecipitation by HPLC with on-line liquid scintillation counting.

100 ody scintigraphy, autoradiography, and gamma scintillation counting.

101 ctivity concentration was measured by liquid scintillation counting.

102 hy, the 3H activity was determined by liquid scintillation counting.

103 tography (HPLC) with detection by continuous scintillation counting.

104 abeled DNA to the bead-immobilized enzyme by scintillation counting.

105 ion of I2 with subsequent analysis by liquid scintillation counting.

106 intravenous administration and up to 48 h by scintillation counting.

107 yer chromatography, and quantified by liquid scintillation counting.

108 cally added (65)Zn and subsequent whole-body scintillation counting.

109 sotope retention was monitored by whole-body scintillation counting.

110 nce liquid chromatography and quantitated by scintillation counting.

111 ioactivity of each fraction is determined by scintillation counting.

112 concentrations in the whole brain by liquid scintillation counting.

113 ing levels of [3H]thymidine incorporation by scintillation counting.

114 ed conjugate present is determined by liquid scintillation counting.

115 sists of an 8 x 8 array of 2 x 2 x 10-mm LSO scintillation crystals that are coupled to a 64-channel

116 rotocol uses solid-phase microextraction and scintillation detection as analytical tools to quantify

117 developed for simultaneous concentration and scintillation detection of technetium-99 in water.

118 free column volume), which is placed into a scintillation detection system to obtain pulse height sp

119 Using a NaI(Tl) scintillation detector designed to operate in electrical

120 Much higher alpha-scintillation efficiency has been obtained for the (241)

121 Among other realistic simulations of scintillation events in clinical positron-emission tomog

122 mal coating conditions were determined, both scintillation fiber and resin functions were retained, p

123 ed compounds, than conventional SPA beads or scintillation fluid (emitting at 400 to 480 nm region).

124 blished by the addition of a phase partition scintillation fluid (PPSF).

125 The PPSF serves as a scintillation fluid, a phase partition agent, and a carr

126 coronary arteries on in vivo imaging using a scintillation gamma camera.

127 e reported including, notably, intense X-ray scintillation in Cs3TbSi4O10F2.

128 sium rare earth silicates exhibiting intense scintillation in several ranges of the visible spectrum

129 intillation measurements with XRIL, the fast scintillation in ZnO crystals was found to be strongly c

130 charge-coupled-device camera to capture the scintillation light excited by an electron-emitting obje

131 The scintillation light is transmitted to position-sensitive

132 nyltoluene) matrices resulting in comparable scintillation light output and neutron capture as state-

133 pertechnetate detection by the absorption of scintillation light pulses (color quench).

134 An optical light guide transmits the scintillation light to the flat-panel multianode positio

135 MS), alpha spectrometry, Cerenkov and liquid scintillation (LS) counting.

136 By combining scintillation measurements with XRIL, the fast scintilla

137 whose interpretation is severely impaired by scintillation noise.

138 ntillation proximity assay (SPA) beads and a scintillation plate counter.

139 (131)I in each body was measured at 2 d by a scintillation probe.

140 External scintillation probes with coincidence detection circuitr

141 XRIL technique for the study of emission and scintillation properties of materials.

142 ra is strongly tied to both the physical and scintillation properties of the crystals.

143 The luminescence and scintillation properties of ZnO single crystals were stu

144 rmat described is called an aaRS competitive scintillation proximity assay (cSPA).

145 Identified "hits" were then confirmed in a scintillation proximity assay (SPA) and a DEAE membrane-

146 neous proximity assays for tyrosine kinases, scintillation proximity assay (SPA) and homogeneous time

147 e obtained from the conventional assay using scintillation proximity assay (SPA) beads and a scintill

148 By using wheat germ agglutinin (WGA)-coated scintillation proximity assay (SPA) beads to capture 125

149 mer was immobilized onto streptavidin-coated scintillation proximity assay (SPA) beads, and after add

150 We describe the first validated scintillation proximity assay (SPA) binding method for q

151 Here we report the development of a coupled scintillation proximity assay (SPA) for 3 KDMs: KDM1A (L

152 A homogeneous scintillation proximity assay (SPA) for detection of RNA

153 hput, we have developed a novel, homogeneous scintillation proximity assay (SPA) for DGAT.

154 We have developed a novel 96-well plate scintillation proximity assay (SPA) for measuring small

155 A simple, high-throughput scintillation proximity assay (SPA) for parathyroid horm

156 using biotinylated NAD, we have developed a scintillation proximity assay (SPA) for PARP.

157 Here we report a 96-well homogeneous scintillation proximity assay (SPA) for the study of Dna

158 stone deacetylase assay that is based on the scintillation proximity assay (SPA) principle.

159 fatty acid amide hydrolase (FAAH) using the scintillation proximity assay (SPA) technology is descri

160 , and homogeneous binding assay based on the scintillation proximity assay (SPA) technology that prov

161 o previously reported procedures: the use of scintillation proximity assay (SPA) technology to measur

162 (RPA) with the quantification advantages of scintillation proximity assay (SPA) technology.

163 H2 domain with a phosphopeptide ligand using scintillation proximity assay (SPA) technology.

164 We have developed a quantitative scintillation proximity assay (SPA) that reproduces the

165 We have adapted and optimized a scintillation proximity assay (SPA) to replace the more

166 A scintillation proximity assay (SPA) using 33phosphorous

167 A scintillation proximity assay (SPA) was developed to det

168 tosaminyltransferase (GalNAc-transferase) by scintillation proximity assay (SPA) was developed.

169 We have developed a scintillation proximity assay (SPA) where use of biotiny

170 de triphosphatase activity was measured in a scintillation proximity assay (SPA)-based high-throughpu

171 metal ion affinity chromatography (IMAC) and scintillation proximity assay (SPA).

172 ter-binding format or by a novel homogeneous scintillation proximity assay (SPA).

173 es than on DNA-core-trimmed nucleosomes in a scintillation proximity assay (SPA).

174 In combination with the scintillation proximity assay (SPA[trade]), this allows

175 e use of AMP-PCP coupled with the use of the scintillation proximity assay allows this characterizati

176 high-throughput screening, are described: a scintillation proximity assay and a time-resolved fluore

177 cts by immobilization on streptavidin-coated scintillation proximity assay beads.

178 method described here is the first reported scintillation proximity assay for a peroxisome prolifera

179 A scintillation proximity assay for measurement of 3H-radi

180 A scintillation proximity assay for peroxisome proliferato

181 (50) values obtained by FP binding assay and scintillation proximity assay for the clinically used PP

182 assay for acetyl CoA carboxylase (ACC) in a scintillation proximity assay format suitable for high-t

183 To our knowledge this ACC/FAS coupled scintillation proximity assay is the only assay format t

184 PAR ligands obtained in FP binding assay and scintillation proximity assay or gel filtration binding

185 d the purified DII S1-S4 protein to create a scintillation proximity assay suitable for high-throughp

186 roduct is then directly quantified using the scintillation proximity assay technology: binding of the

187 distinct inhibitory profile, we developed a scintillation proximity assay that permits analysis of r

188 The screen uses a scintillation proximity assay to identify compounds that

189 The soluble receptor was used in a scintillation proximity assay to identify two chemical c

190 We now describe a scintillation proximity assay to measure soluble inosito

191 try of the targeting process, we developed a scintillation proximity assay to study the stepwise asso

192 format for the detection of inhibition is a scintillation proximity assay which is robust and reprod

193 Using the antibody-capture [(35)S]GTPgammaS scintillation proximity assay, we demonstrated for the f

194 y were determined using this FP method and a scintillation proximity assay.

195 rsible loss of ligand binding as assessed by scintillation proximity assay.

196 rs of human DNA topoisomerase I based on the scintillation proximity assay.

197 (3)H]troglitazone, a PPARgamma agonist, in a scintillation proximity assay.

198 ified biochemically with a cytosol-dependent scintillation proximity assay.

199 We developed scintillation proximity assays (SPA) to discover compoun

200 Scintillation proximity assays designed to look at the b

201 ration calorimetry, equilibrium dialysis and scintillation proximity assays.

202 nding and peptide-myristoylation activity in scintillation proximity assays.

203 SH2 domains was monitored utilizing a novel scintillation proximity based assay.

204 anded nucleic acid complex on the surface of scintillation proximity beads derivatized with streptavi

205 d RNA can be captured on streptavidin-coated scintillation proximity beads.

206 A novel scintillation proximity competitive hybridization assay

207 cts radioactive S1P adhering to the plate by scintillation proximity counting.

208 A novel scintillation proximity high throughput assay (SPA) to i

209 d, the final product, is readily detected by scintillation proximity in a FlashPlate or Image FlashPl

210 ) 384-well format using a modified published scintillation proximity method.

211 upled device (CCD) camera and newly designed scintillation proximity microparticles.

212 Scintillation proximity offers an equilibrium method for

213 bined with site-directed mutagenesis and the scintillation proximity radioligand binding assay improv

214 cally by monitoring ligase-AMP formation via scintillation proximity technologies.

215 ing a ligand binding assay that incorporates scintillation proximity technology to circumvent many of

216 96-well membrane plate assay and a 384-well scintillation proximity-based assay developed herein.

217 Here, we describe a direct scintillation proximity-based radioligand-binding assay

218 The molecule exhibits activity in a scintillation-proximity assay for the inhibition of the

219 We have developed a cell-free and scintillation-proximity assay-based screen to search for

220 oactive decay of Tc-99 results in detectable scintillation pulses that are counted in coincidence.

221 The scintillation response of poly(ethersulfone)-based membr

222 n seawater by way of state-of-the-art liquid scintillation spectrometry.

223 sed and the radioactivity measured by liquid scintillation spectrometry.

224 sed and the radioactivity measured by liquid scintillation spectrometry.

225 gh pressure liquid chromatography (HPLC) and scintillation spectrometry.

226 3521 were assayed by both radiolabel (liquid scintillation spectroscopy) and CGE methods.

227 ivity (by [(14)C]-5-HT metabolism and liquid scintillation spectroscopy) were measured in human neuro

228 The burst scintillation suggests weak turbulence in the ionized in

229 Using a novel miniaturized light-scintillation technique, we quantified a strong retrogra

230 ed protein products are eluted directly into scintillation vials and counted.

231 mples the assay can be conducted entirely in scintillation vials and quantitated by addition of appro

232 rol (N = 10), identified both by imaging and scintillation well counting.